Aveanna Healthcare Holdings Inc (AVAH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $2.51B
Last updated: Nov 17, 2026 at 11:04 AM ET
Aveanna Healthcare Holdings Inc (AVAH) Earnings: Report Dates and Results
Aveanna Healthcare Holdings (AVAH) is expected to report earnings on Mar 19, 2027. In the quarter ended Sep 30, 2026, Aveanna Healthcare Holdings reported EPS of $0.22, above the $0.19 estimate. It beat the EPS estimate in each of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
AVAH has an expected report date of Mar 19, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 23.5% above the $0.17 reported for the quarter ended Dec 31, 2025.
AVAH Earnings Call
The latest AVAH earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 20 quarters below that had an estimate, AVAH beat 11, missed 7 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $695.54M, up 11.8% from $621.94M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.22 | $0.19 | $0.19 - $0.23 | +15.79% | Beat | +46.7% | 10 | 2 up, 0 down | Nov 12, 2026 | $695.54M |
| Jun 30, 2026 | $0.21 | $0.16 | $0.15 - $0.18 | +31.25% | Beat | +31.2% | 11 | 2 up, 0 down | Aug 13, 2026 | $670.48M |
| Mar 31, 2026 | $0.18 | $0.13 | $0.11 - $0.15 | +38.46% | Beat | +80.0% | 11 | 3 up, 1 down | May 14, 2026 | $647.91M |
| Dec 31, 2025 | $0.17 | $0.13 | $0.11 - $0.18 | +28.89% | Beat | +240.0% | 9 | 0 up, 0 down | Mar 19, 2026 | $662.48M |
| Sep 30, 2025 | $0.15 | $0.13 | $0.09 - $0.19 | +15.38% | Beat | +650.0% | 3 | 1 up, 0 down | Nov 6, 2025 | $621.94M |
| Jun 30, 2025 | $0.16 | $0.01 | N/A | N/A | N/A | +1500.0% | 9 | 3 up, 1 down | Aug 7, 2025 | $589.55M |
| Mar 31, 2025 | $0.10 | $0.00 | -$0.02 - $0.01 | N/A | N/A | N/A | 7 | 4 up, 2 down | May 8, 2025 | $559.22M |
| Dec 31, 2024 | $0.05 | $0.00 | -$0.01 - $0.01 | N/A | N/A | N/A | 7 | 1 up, 3 down | Mar 13, 2025 | $519.87M |
| Sep 30, 2024 | $0.02 | -$0.01 | -$0.02 - $0.01 | +300.00% | Beat | N/A | 8 | 0 up, 0 down | Nov 7, 2024 | $509.02M |
| Jun 30, 2024 | $0.01 | -$0.02 | -$0.03 - -$0.01 | +150.00% | Beat | N/A | 7 | 0 up, 0 down | Aug 8, 2024 | $504.96M |
| Mar 31, 2024 | -$0.03 | -$0.05 | -$0.06 - -$0.03 | +40.00% | Beat | N/A | 8 | 0 up, 0 down | May 9, 2024 | $490.65M |
| Dec 31, 2023 | -$0.02 | -$0.02 | -$0.03 - -$0.01 | 0.00% | In line | N/A | 8 | 0 up, 0 down | Mar 14, 2024 | $478.84M |
| Sep 30, 2023 | -$0.03 | -$0.02 | -$0.04 - -$0.01 | -50.00% | Miss | N/A | 6 | 1 up, 0 down | Nov 9, 2023 | $478.01M |
| Jun 30, 2023 | -$0.02 | -$0.04 | -$0.05 - -$0.02 | +50.00% | Beat | -166.7% | 8 | 0 up, 0 down | Aug 10, 2023 | $471.94M |
| Mar 31, 2023 | -$0.05 | -$0.06 | -$0.07 - -$0.04 | +16.67% | Beat | -225.0% | 6 | 0 up, 0 down | May 11, 2023 | $466.41M |
| Dec 31, 2022 | -$0.03 | -$0.02 | -$0.04 - $0.02 | -50.00% | Miss | -130.0% | 7 | 0 up, 0 down | Mar 16, 2023 | $451.15M |
| Sep 30, 2022 | -$0.03 | $0.04 | $0.01 - $0.06 | -175.00% | Miss | -127.3% | 9 | 0 up, 0 down | Nov 9, 2022 | $443.01M |
| Jun 30, 2022 | $0.03 | $0.07 | $0.02 - $0.10 | -57.14% | Miss | -70.0% | 9 | 0 up, 0 down | Aug 10, 2022 | $442.95M |
| Mar 31, 2022 | $0.04 | $0.06 | $0.04 - $0.09 | -33.33% | Miss | -50.0% | 10 | 0 up, 0 down | May 11, 2022 | $450.53M |
| Dec 31, 2021 | $0.10 | $0.11 | $0.09 - $0.14 | -9.09% | Miss | +15.6% | 10 | N/A | Mar 28, 2022 | $414.07M |
| Sep 30, 2021 | $0.11 | $0.12 | $0.10 - $0.14 | -8.33% | Miss | N/A | 10 | 3 up, 0 down | Nov 15, 2021 | $411.28M |
| Jun 30, 2021 | $0.10 | $0.10 | $0.08 - $0.12 | 0.00% | In line | N/A | 10 | N/A | Aug 11, 2021 | $436.11M |
| Mar 31, 2021 | $0.08 | $0.07 | N/A | +14.29% | Beat | N/A | N/A | N/A | Apr 30, 2021 | $417.16M |
| Dec 31, 2020 | $0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 3, 2021 | $422.30M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.58, up 1060.0% from the year before. It was $0.09 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.58 | +1060.0% |
| Dec 31, 2024 | $0.05 | N/A |
| Dec 31, 2023 | -$0.12 | -1300.0% |
| Dec 31, 2022 | $0.01 | -97.4% |
| Dec 31, 2021 | $0.39 | +350.9% |
| Dec 31, 2020 | $0.09 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,600 words across 12 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,617 | 12 | |
| 2026Q2 | Jun 30, 2026 | 7,261 | 14 | |
| 2026Q1 | Mar 31, 2026 | 7,682 | 15 | |
| 2025Q4 | Dec 31, 2025 | 7,935 | 13 | |
| 2025Q3 | Sep 30, 2025 | 8,589 | 13 | |
| 2025Q2 | Jun 30, 2025 | 8,223 | 11 | |
| 2025Q1 | Mar 31, 2025 | 6,970 | 9 | |
| 2024Q4 | Dec 31, 2024 | 6,592 | 8 |
2026Q3 Earnings Call
Opening remarks
Debbie Stewart Chief Accounting Officer Good morning, and welcome to Aveanna's third quarter 2026 earnings call. I am Debbie Stewart, the company's Chief Accounting Officer. With me today is Jeff Shaner, our Chief Executive Officer, and Matt Buckhalter, our Chief Financial Officer. During this call, we will make forward-looking statements. Risk factors that may impact those statements and could cause actual future results to differ materially from currently projected results are described in this morning's press release and the reports we file with the SEC. The company does not undertake any duty to update such forward-looking statements. Additionally, during today's call, we will discuss certain non-GAAP measures, which we believe can be useful in evaluating our performance. The presentation of this additional information should not be considered in isolation or as a substitute for results prepared in accordance with GAAP. A reconciliation of these measures can be found in this morning's press release, which is posted on our website, aveanna.com, and in our most recent quarterly report on Form 10-Q when filed. With that, I will turn the call over to Aveanna's Chief Executive Officer, Jeff Shaner. Jeff?
Jeffrey Shaner CEO Thank you, Debbie. Good morning, and thank you for joining us today. We appreciate each of you investing your time this morning to better understand our Q3 results and how we are finishing full year 2026 with solid momentum. My initial comments will briefly highlight our third quarter results, along with the steps we are taking to address the labor markets and our ongoing efforts with government and preferred payers to create additional capacity. I will then provide updates on the Family First integration, how we are progressing with our 2026 strategic initiatives, our enhanced guidance, and reconfirm our long-term growth outlook before turning the call over to Matt. Let's move to highlights for the third quarter. Revenue for the third quarter was $695.5 million, representing an 11.8% increase over the prior year period. Third quarter adjusted EBITDA was $100.1 million, representing a 25% increase over the prior year period, primarily due to the improved rate and volume environment and continued operational efficiencies. As we have previously discussed, the labor environment represented the primary challenge that we needed to address to see Aveanna resume the growth trajectory that we believed our company could achieve. It is important to note that our industry does not have a demand problem. The demand for home and community-based care continues to be burgeoning, with both state and federal governments and managed care organizations asking for solutions that create more capacity while reducing the total cost of care. Our Q3 results highlight that we continue to align our objectives with those of our preferred payers and government partners.
Frequently Asked Questions About AVAH
When is Aveanna Healthcare Holdings's next earnings date?
Aveanna Healthcare Holdings's next earnings report is expected for Mar 19, 2027.
Did AVAH beat earnings estimates last quarter?
Yes. Aveanna Healthcare Holdings reported EPS of $0.22 for the quarter ended Sep 30, 2026, above the $0.19 estimate, a 15.79% surprise.
What EPS do analysts expect from AVAH next quarter?
The consensus EPS estimate for Aveanna Healthcare Holdings for the quarter ending Dec 31, 2026 is $0.21 from 12 analysts, with estimates from $0.19 to $0.24.
How often does AVAH beat earnings estimates?
Aveanna Healthcare Holdings beat the EPS estimate in each of the 8 most recent quarters that had an estimate, with an average surprise of +77.47%.
AVAH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors